D020714Concepts & IdeasE05.940.481G07.690.936.625902700.919887Maximum Tolerated Doseprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson28458054Guo W, Wang SJ, Yang S, Lynn H, Ji YContemporary clinical trialsA Bayesian interval dose-finding design addressingOckham's razor: mTPI-2. Contemp Clin Trials. 2017 07; 58:23-33.Contemp Clin Trials2017-04-27T00:00:002017A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2.Medicine-Hematology and Oncology34543056Ratain MJ, Tannock IF, Lichter ASJournal of clinical oncology : official journal of the American Society of Clinical OncologyDose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message? J Clin Oncol. 2021 11 01; 39(31):3423-3426.J Clin Oncol2021-09-20T00:00:002021Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message?34994645Ji Y, Yuan SJCO precision oncologyPractical Impact of Modern Dose-Finding Designs When Compared With the 3 + 3 Design: An Editorial. JCO Precis Oncol. 2021 11; 5:1584-1587.JCO Precis Oncol2021-11-01T00:00:002021Practical Impact of Modern Dose-Finding Designs When Compared With the 3 + 3 Design: An Editorial.Public Health SciencesYuanJi7khgK6kQGODNmTRmc0Kg5mby9si87roQdX1vYuan Ji0.000000000000000.000000000000003110Ji, YuanProfessorhttps://ccte.uchicago.edu/Yuan Ji's Biostatistics and Bioinformatics Lab (BBL)2.447790.008025190research area of0.846360.034896179subject area forMedicineUniversity of ChicagoMark J.RatainMark J. Ratain41.78927490000000-87.601250000000001401Ratain, Mark J.ProfessorWendyStockwHF9BKIeOfnamXNnYUHhvWD+6g==Wendy Stock41.78927490000000-87.601250000000001502Stock, WendyProfessorEverett E.VokesEverett E. Vokes41.78927490000000-87.601250000000001920Vokes, Everett E.ProfessorTheodoreKarrisonTheodore Karrison41.78927490000000-87.601250000000002356Karrison, TheodoreResearch Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Research ProfessorResearch Professortrue1ProfessorProfessor26467385Sharma MR, Ratain MJClinical cancer research : an official journal of the American Association for Cancer ResearchTaking a Measured Approach to Toxicity Data in Phase I Oncology Clinical Trials. Clin Cancer Res. 2016 Feb 01; 22(3):527-9.Clin Cancer Res2015-10-14T00:00:002015Taking a Measured Approach to Toxicity Data in Phase I Oncology Clinical Trials.27356783Xiao DY, Luo S, O'Brian K, Ganti A, Riedell P, Sanfilippo KM, Lynch RC, Liu W, Carson KRAmerican journal of hematologyImpact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy. Am J Hematol. 2016 10; 91(10):1002-7.Am J Hematol2016-07-22T00:00:002016Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy.